XML 10 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
Revenue $ 169,180 $ 138,477
Cost of sales 53,184 41,126
Gross profit 115,996 97,351
Operating expenses:    
Research and development 16,582 18,012
Sales, general and administrative 127,017 113,610
Litigation-related expenses 12,214 4,428
Amortization expense 4,103 3,854
Restructuring expenses 371 788
Total operating expenses 160,287 140,692
Operating loss (44,291) (43,341)
Other expense, net:    
Interest expense, net (7,841) (5,341)
Loss on debt extinguishment (17,576) 0
Gain on derivative liability 17,400 0
Other income, net 337 118
Total other expense, net (7,680) (5,223)
Net loss before taxes (51,971) (48,564)
Income tax benefit (64) (69)
Net loss $ (51,907) $ (48,495)
Net loss per share, basic $ (0.35) $ (0.34)
Net loss per share, diluted $ (0.35) $ (0.34)
Weighted average shares outstanding, basic 146,732 140,980
Weighted average shares outstanding, diluted 146,732 140,980
Products and Services    
Revenue:    
Revenue $ 169,180 $ 138,477